Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open-Label, Multi-Center, Non-Significant Risk Study of Nano-Pulse Stimulation™ (NPS™) Technology in Healthy Adults With Seborrheic Keratosis

NCT04249115 is registered in ClinicalTrials.gov with Pulse Biosciences, Inc. as lead sponsor.

NCT NCT04249115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04249115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open-Label, Multi-Center, Non-Significant Risk Study of Nano-Pulse Stimulation™ (NPS™) Technology in Healthy Adults With Seborrheic Keratosis
Lead sponsor
Pulse Biosciences, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
February 5, 2019
Completion date
April 22, 2021
Enrollment
175 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

benign skin tumor, lesion skin, seborrheic keratosis, skin lesion